| Net loss | -17.71M |
| Loss (income) from discontinued operations | |
| Equity compensation and administrative expenses | 6.22M |
| Depreciation and amortization | 122K |
| Disposal of equipment | |
| Amortization of debt discount and financing costs | |
| Allowance for doubtful accounts | |
| Inventory excess and obsolescence adjustments | |
| Change in fair value of warrant liabilities | |
| (Increase) decrease in accounts receivable | |
| (Increase) decrease in inventories | |
| Increase in other current assets | 28K |
| (Decrease) increase in accounts payable, accrued expenses and other liabilities | 1.8M |
| Net cash provided by discontinued operations | |
| Net Cash (Used In) Provided by Operating Activities | -982K |
| Collections of notes receivable | |
| Decrease (increase) in other assets | |
| Payments for property and equipment | -1K |
| Net cash used by discontinued operations | |
| Net Cash Provided by Investing Activities | -1K |
| Cash Flows From Financing Activities | |
| Amounts paid on notes payable | |
| Net borrowings of debt | |
| Stock issuance costs | |
| Financing costs | |
| Net cash used by discontinued operations | |
| Net Cash Provided by (Used in) Financing Activities | 909K |
| Proceeds from sale of Debentures | |
| Net Increase In Cash and Cash Equivalents | -74K |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | |
| Cash and Cash Equivalents – Beginning of Period | 77K |
| Cash and Cash Equivalents – End of Period | 3K |
| Cash Flows From Financing Activities | |
| Sale of common stock | 20K |
| Cash Flows From Financing Activities | |
| Sale of common stock | |